PALATIN TECHNOLOGIES INC
PALATIN TECHNOLOGIES INC (PTN): 8 pipeline candidates · 1 upcoming catalyst · ~7 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
7.4 months
D/E 0.25 · 120% dilution
Lead: Phase 3
8 candidates
1 upcoming, next in ~5429d
0 buys · 1 sell (180d)
A transparent, data-derived signal for PALATIN TECHNOLOGIES INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$22.2M
Cash
$10.2M
Quarterly Burn
$4.4M
Runway
7.4 mo
Revenue
$3.9M
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (8 candidates)
| Drug | Phase |
|---|---|
| bremelanotide | Preclinical |
| bremelanotide + pde5i | Phase 3 |
| bremelanotide + tirzepatide | Phase 2 |
| pl-3994 aqueous intravenous solution dose ascention | Phase 2 |
| pl-3994 aqueous intravenous solution single dose | Phase 2 |
| pl7737 | Preclinical |
| pl8177 | Phase 2 |
| pl9643 | Phase 3 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
25
Total value held
$14.8M
| Holder | Shares | Value |
|---|---|---|
| janus henderson group plc | 280,000 | $4.9M |
| driehaus capital management llc | 166,713 | $2.9M |
| perceptive advisors llc | 123,890 | $2.2M |
| ra capital management, l.p. | 70,000 | $1.2M |
| balyasny asset management l.p. | 41,169 | $717K |
| vanguard capital management llc | 37,958 | $661K |
| superstring capital management lp | 35,969 | $627K |
| morgan stanley | 27,272 | $475K |
| geode capital management, llc | 18,502 | $322K |
| miller financial services llc | 12,600 | $219K |
Showing top 10 of 25 institutional holders of PALATIN TECHNOLOGIES INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in PALATIN TECHNOLOGIES INC's pipeline?
PALATIN TECHNOLOGIES INC (PTN) has 8 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is PALATIN TECHNOLOGIES INC's lead drug candidate?
PALATIN TECHNOLOGIES INC's most advanced tracked candidate is bremelanotide (Preclinical) for Erectile Dysfunction.
What is PALATIN TECHNOLOGIES INC's next catalyst?
PALATIN TECHNOLOGIES INC's next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: VYLEESI (AUTOINJECTOR)" — expected April 29, 2041.
What is PALATIN TECHNOLOGIES INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, PALATIN TECHNOLOGIES INC has approximately 7.4 months of cash runway.
What is PALATIN TECHNOLOGIES INC's market capitalization?
PALATIN TECHNOLOGIES INC's market capitalization is approximately $22.2M.
Get the full picture on PALATIN TECHNOLOGIES INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.